Range Financial Group LLC bought a new stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 201,526 shares of the company’s stock, valued at approximately $2,975,000. Range Financial Group LLC owned about 0.15% of Perrigo at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Parrish Capital LLC grew its stake in shares of Perrigo by 4.3% during the 2nd quarter. Parrish Capital LLC now owns 33,896 shares of the company’s stock valued at $352,000 after purchasing an additional 1,384 shares during the period. Abel Hall LLC lifted its stake in shares of Perrigo by 14.0% in the 3rd quarter. Abel Hall LLC now owns 14,630 shares of the company’s stock worth $216,000 after purchasing an additional 1,797 shares during the period. KBC Group NV lifted its stake in shares of Perrigo by 61.3% in the 1st quarter. KBC Group NV now owns 6,283 shares of the company’s stock worth $67,000 after purchasing an additional 2,388 shares during the period. Janney Montgomery Scott LLC boosted its holdings in shares of Perrigo by 9.6% in the first quarter. Janney Montgomery Scott LLC now owns 35,053 shares of the company’s stock worth $376,000 after buying an additional 3,073 shares during the last quarter. Finally, SteelPeak Wealth LLC boosted its holdings in shares of Perrigo by 20.8% in the third quarter. SteelPeak Wealth LLC now owns 22,369 shares of the company’s stock worth $330,000 after buying an additional 3,853 shares during the last quarter. 95.91% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
PRGO has been the subject of several analyst reports. Wall Street Zen lowered Perrigo from a “strong-buy” rating to a “buy” rating in a research note on Sunday, September 27th. Weiss Ratings upgraded Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research report on Thursday, August 6th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $19.33.
Check Out Our Latest Research Report on Perrigo
Perrigo Price Performance
Shares of Perrigo stock opened at $16.17 on Wednesday. The firm has a market cap of $2.24 billion, a PE ratio of -1.29, a PEG ratio of 1.84 and a beta of 0.69. The stock has a 50 day moving average of $14.41 and a 200 day moving average of $12.16. The company has a current ratio of 2.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.31. Perrigo Company plc has a 12 month low of $9.23 and a 12 month high of $22.02.
Perrigo (NYSE:PRGO – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.11. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%. The company’s revenue was down 3.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.06) EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, research analysts expect that Perrigo Company plc will post 2.18 EPS for the current fiscal year.
Perrigo Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Friday, August 28th were paid a dividend of $0.29 per share. The ex-dividend date of this dividend was Friday, August 28th. This represents a $1.16 dividend on an annualized basis and a yield of 7.2%. Perrigo’s dividend payout ratio is presently -9.27%.
About Perrigo
Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.
Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.
Featured Articles
- Five stocks we like better than Perrigo
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.
